CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.31%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$413M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
725
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$45.5M |
| 2 |
Gilead Sciences
GILD
|
$39.4M |
| 3 |
GE Aerospace
GE
|
$36.8M |
| 4 |
Motorola Solutions
MSI
|
$26M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$24.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$55.4M |
| 2 |
Amgen
AMGN
|
$30M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$23.3M |
| 4 |
Canadian National Railway
CNI
|
$21.7M |
| 5 |
Becton Dickinson
BDX
|
$18.5M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Martin Marietta Materials
MLM
$37.5B
| $962K | 0.02% |
4,408
-617
| -12% | -$135K |
|
|
VAR
552
DELISTED
Varian Medical Systems, Inc.
VAR
| $934K | 0.02% |
10,245
+2,604
| +34% | +$237K |
|
|
XL
553
DELISTED
XL Group Ltd.
XL
| $928K | 0.02% |
23,291
+3,773
| +19% | +$150K |
|
554
Expedia Group
EXPE
$26.6B
| $925K | 0.02% |
7,331
+1,897
| +35% | +$239K |
|
555
Everest Group
EG
$14.3B
| $923K | 0.02% |
3,946
+352
| +10% | +$82.3K |
|
556
Huntington Ingalls Industries
HII
$10.6B
| $917K | 0.02% |
+4,577
| New | +$917K |
|
557
vTv Therapeutics
VTVT
$47.9M
| $917K | 0.02% |
+3,500
| New | +$917K |
|
558
Avnet
AVT
$4.49B
| $915K | 0.02% |
20,000
| – | – |
|
559
Invesco
IVZ
$9.81B
| $908K | 0.02% |
29,656
+6,905
| +30% | +$211K |
|
560
Pembina Pipeline
PBA
$22.1B
| $906K | 0.02% |
28,664
+2,367
| +9% | +$74.8K |
|
561
Rogers Communications
RCI
$19.4B
| $904K | 0.02% |
20,501
-20,158
| -50% | -$889K |
|
562
Bread Financial
BFH
$3.09B
| $895K | 0.02% |
4,506
+602
| +15% | +$120K |
|
563
Masco
MAS
$15.9B
| $891K | 0.02% |
26,222
+5,312
| +25% | +$180K |
|
564
TransDigm Group
TDG
$71.6B
| $872K | 0.02% |
3,960
+433
| +12% | +$95.3K |
|
565
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $871K | 0.02% |
22,109
| – | – |
|
|
CBIO
566
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $869K | 0.02% |
1,600
| – | – |
|
567
Aurinia Pharmaceuticals
AUPH
$1.63B
| $866K | 0.02% |
+118,000
| New | +$866K |
|
|
DNB
568
DELISTED
Dun & Bradstreet
DNB
| $863K | 0.02% |
7,995
| – | – |
|
569
AXIS Capital
AXS
$7.62B
| $862K | 0.02% |
12,854
| – | – |
|
|
CHL
570
DELISTED
China Mobile Limited
CHL
| $852K | 0.02% |
15,420
| – | – |
|
571
RenaissanceRe
RNR
$11.3B
| $850K | 0.02% |
5,877
+518
| +10% | +$74.9K |
|
572
Corpay
CPAY
$22.4B
| $844K | 0.02% |
5,574
+1,582
| +40% | +$240K |
|
|
QVCGA
573
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $842K | 0.02% |
867
+128
| +17% | +$124K |
|
574
Albemarle
ALB
$9.6B
| $836K | 0.02% |
+7,910
| New | +$836K |
|
575
CarMax
KMX
$9.11B
| $836K | 0.02% |
14,118
+3,131
| +28% | +$185K |
|